Search Results - "Cervera, Raquel"

Same-Day Desensitization in Patients Who Experience Their First Reaction to a Platin Agent at the Oncology Day Unit: A Pilot Study to Safely Include This Technique Within the Multidisciplinary Pathways for the Diagnosis & Management of Hypersensitivity to Platin Agents by Borrás Cuartero, Julián, Farzanegan Miñano, Roxana, Torres Gorriz, María Cruz, Germán Sánchez, Adrián, Aznar, Raquel Cervera, Raducan, Isabela, Castelló Carrascosa, Jose Vicente, Sanchez Hernandez, Alfredo, Enrique, Ernesto

“…One of the main objectives when assessing patients who react to antineoplastics must be to ensure that they receive the required treatments without delay. From…”
Get full text

Cutaneous reaction to ifosfamide plus mesna treated with desensitization challenge: a case report by Delgado-Prada, Ana, Borrás, Julián, Farzanegan, Roxana, Torres Gorriz, María Cruz, Germán-Sánchez, Adrián, Cervera Aznar, Raquel, Raducan, Isabela, Castelló, Jose Vicente, Sanchez-Hernandez, Alfredo, Enrique, Ernesto

“…Ifosfamide is an alkylating agent used in the treatment of a wide range of tumours. Because of known side effects it is usually administered in combination…”
Get full text

Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy by Gonzalez Guzman, Luis Alfredo, García Robaina, Jose Carlos, Barrios Recio, Javier, Escudero Arias, Elena, Liñares Mata, Tania, Cervera Aznar, Raquel, De La Roca Pinzón, Federico, Miguel Polo, Lissette Del Carmen, Arenas Villarroel, Luis, López Couso, Verónica P, Alcover Diaz, Javier, Rodriguez Gil, David, Pelaez, Ricardo Palacios, Carballada Gonzalez, Francisco Javier

“…The aim of this study is to explore the safety and efficacy of bee venom immunotherapy without HSA, in real-life patients. Methods: This is an observational…”
Get full text

Evolocumab as treatment in lorlatinib-related hyperlipidemia by Pérez Alonso, Laura, Cervera Calero, Raquel, Campos Fernández de Sevilla, María Ángeles, Moreno Palanco, Miguel Ángel, Gómez Cerezo, Jorge Francisco

“…Anti-PCSK9 monoclonal antibodies have reduced the risk of cardiovascular events in patients with atheroesclerosis cardiovascular disease. However, its use has…”
Get more information

Utilidad del tratamiento con atorvastatina 40 mg más ezetimiba 10 mg frente a atorvastatina 80 mg en la reducción de los niveles de colesterol LDL en pacientes con ictus isquémico o ataque isquémico transitorio by Palacio Portilla, Enrique, Viadero Cervera, Raquel, Revilla García, M. Ángeles, Larrosa Campo, Davinia, Acha Salazar, Olga, Novo Robledo, Francisco, Oterino Durán, Agustín

Get full text

Trying to define “high tumor burden” in non-small cell lung cancer: A Delphi survey by Mielgo-Rubio, Xabier, Sereno, Maria, Higuera, Oliver, Cervera, Raquel, Cabezon-Gutierrez, Luis

“…e21061 Background: High tumor burden (HTB) has been introduced in several solid tumors as clinical biomarker with negative prognostic value and has also been…”
Get full text

SUV max ratio as a novel prognostic factor in advanced colorectal cancer by Sanchez, Victoria, Villa, Jose Carlos, Cervera, Raquel, Rafael, Lopez, Galan, Rocio, Cano, Juana Maria, Espinosa, Javier

“…Abstract only…”
Get full text

New horizons for uncommon mutations in non-small cell lung cancer: BRAF , KRAS , RET , MET , NTRK , HER2 by Olmedo, Maria Eugenia, Cervera, Raquel, Cabezon-Gutierrez, Luis, Lage, Yolanda, Corral de la Fuente, Elena, Gómez Rueda, Ana, Mielgo-Rubio, Xabier, Trujillo, Juan Carlos, Couñago, Felipe

“…The 2004 discovery of mutations, followed by rearrangements, ushered in a targeted therapy era for advanced non-small cell lung cancer (NSCLC). Tyrosine kinase…”
Get full text

Utility of treatment with atorvastatin 40 mg plus ezetimibe 10 mg versus atorvastatin 80 mg in reducing the levels of LDL cholesterol in patients with ischaemic stroke or transient ischaemic attack by Palacio, Enrique, Viadero-Cervera, Raquel, Revilla, Marián, Larrosa-Campo, Davinia, Acha-Salazar, Olga, Novo-Robledo, Francisco, Oterino, Agustín

“…After an ischaemic stroke, to reduce LDL cholesterol (LDLc) levels decreases the risk of recurrence. The risk of recurrence is lower with more intense…”
Get full text

Intraoperative peripheral nerve injury in colorectal surgery. An update by Colsa Gutiérrez, Pablo, Viadero Cervera, Raquel, Morales-García, Dieter, Ingelmo Setién, Alfredo

“…Intraoperative peripheral nerve injury during colorectal surgery procedures is a potentially serious complication that is often underestimated. The…”
Get more information

Gastric and colon metastasis from breast cancer: case report, review of the literature, and possible underlying mechanisms by Villa Guzmán, J Carlos, Espinosa, J, Cervera, R, Delgado, M, Patón, R, Cordero García, J M

“…Gastrointestinal metastases from breast cancer are not common. We present a 58-year-old female diagnosed with lobular breast cancer some years before whose…”
Get full text

Intraoperative Peripheral Nerve Injury in Colorectal Surgery. An Update by Colsa Gutiérrez, Pablo, Viadero Cervera, Raquel, Morales-García, Dieter, Ingelmo Setién, Alfredo

“…Abstract Intraoperative peripheral nerve injury during colorectal surgery procedures is a potentially serious complication that is often underestimated. The…”
Get full text

High tumor burden in patients with non-small-cell lung cancer: a Delphi survey among Spanish oncologists by Sereno, María, Cabezón-Gutiérrez, Luis, Higuera, Oliver, Mielgo-Rubio, Xabier, Cervera-Calero, Raquel

“…To define high tumor burden (HTB) in non-small-cell lung cancer. A total of five oncologists initiated the project, selecting 66 participants, and elaborated a…”
Get full text

High tumor burden in non-small-cell lung cancer: A review of the literature by Cabezón-Gutiérrez, Luis, Sereno, María, Cervera-Calero, Raquel, Mielgo-Rubio, Xabier, Higuera, Oliver

“…Lung cancer is the leading cause of cancer death worldwide and the majority of the patients have advanced/metastatic disease on presentation. In clinical…”
Get full text

Evolocumab como tratamiento de la dislipemia secundaria a lorlatinib by Pérez Alonso, Laura, Cervera Calero, Raquel, Campos Fernández de Sevilla, María Ángeles, Moreno Palanco, Miguel Ángel, Gómez Cerezo, Jorge Francisco

“…Los anticuerpos monoclonales anti-PCSK9 han demostrado reducción de eventos cardiovasculares en pacientes con enfermedad vascular ateroesclerótica1. Sin…”
Get full text